Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Intrinsic Value
Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. engages in the research, development, production, and sale of pharmaceutical packaging materials. [ Read More ]
The intrinsic value of one Shanghai Haishun New Pharmaceutical Packaging Co Ltd stock under the Base Case scenario is 14.36 CNY. Compared to the current market price of 12.15 CNY, Shanghai Haishun New Pharmaceutical Packaging Co Ltd is Undervalued by 15%.
Valuation Backtest
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Run backtest to discover the historical profit from buying and selling Shanghai Haishun New Pharmaceutical Packaging Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
| Current Assets | 1.2B |
| Cash & Short-Term Investments | 656.8m |
| Receivables | 305.9m |
| Other Current Assets | 252.9m |
| Non-Current Assets | 1.7B |
| Long-Term Investments | 394.4m |
| PP&E | 995.5m |
| Intangibles | 129.4m |
| Other Non-Current Assets | 171.6m |
| Current Liabilities | 391.3m |
| Accounts Payable | 103.7m |
| Accrued Liabilities | 7.7m |
| Short-Term Debt | 185.9m |
| Other Current Liabilities | 94m |
| Non-Current Liabilities | 678.7m |
| Long-Term Debt | 549m |
| Other Non-Current Liabilities | 129.8m |
Earnings Waterfall
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
|
Revenue
|
1.1B
CNY
|
|
Cost of Revenue
|
-762.6m
CNY
|
|
Gross Profit
|
294m
CNY
|
|
Operating Expenses
|
-164m
CNY
|
|
Operating Income
|
130m
CNY
|
|
Other Expenses
|
-19.8m
CNY
|
|
Net Income
|
110.2m
CNY
|
Free Cash Flow Analysis
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Profitability Score
Profitability Due Diligence
Shanghai Haishun New Pharmaceutical Packaging Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Haishun New Pharmaceutical Packaging Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Haishun New Pharmaceutical Packaging Co Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Haishun New Pharmaceutical Packaging Co Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Shareholder Return
Price
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
| Average Annual Return | -5.9% |
| Standard Deviation of Annual Returns | 46.84% |
| Max Drawdown | -73% |
| Market Capitalization | 2.4B CNY |
| Shares Outstanding | 193 531 505 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. engages in the research, development, production, and sale of pharmaceutical packaging materials. The company is headquartered in Shanghai, Shanghai and currently employs 688 full-time employees. The company went IPO on 2016-02-04. The firm's major products include cold-forming composite hard sheet, polyterephthalate (PTP) aluminum foil and suppository (SP) films. Other products include polytrifluorochloroethylene (PTFCE) and polyvinyl chloride (PVC) composite hard sheet. Its products are widely used in the packaging of pharmaceutical, such as tablets, pills, capsules, granules, powders and suppositories, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai Haishun New Pharmaceutical Packaging Co Ltd stock under the Base Case scenario is 14.36 CNY.
Compared to the current market price of 12.15 CNY, Shanghai Haishun New Pharmaceutical Packaging Co Ltd is Undervalued by 15%.
You don't have any saved screeners yet
